BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12195372)

  • 1. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of type-specific human papillomavirus infections in female university students.
    Richardson H; Kelsall G; Tellier P; Voyer H; Abrahamowicz M; Ferenczy A; Coutlée F; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):485-90. PubMed ID: 12814991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Brown DR; Elbasha EH; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1585-94. PubMed ID: 20530494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.
    Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S
    Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.
    Giuliano AR; Lu B; Nielson CM; Flores R; Papenfuss MR; Lee JH; Abrahamsen M; Harris RB
    J Infect Dis; 2008 Sep; 198(6):827-35. PubMed ID: 18657037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.
    Muñoz N; Méndez F; Posso H; Molano M; van den Brule AJ; Ronderos M; Meijer C; Muñoz A;
    J Infect Dis; 2004 Dec; 190(12):2077-87. PubMed ID: 15551205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
    Cuschieri KS; Whitley MJ; Cubie HA
    J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy.
    Giovannelli L; Vassallo R; Matranga D; Affronti M; Caleca MP; Bellavia C; Perino A; Ammatuna P
    Acta Obstet Gynecol Scand; 2009; 88(6):737-42. PubMed ID: 19412805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.